Difference between revisions of "Part:BBa K733008"
| Line 1: | Line 1: | ||
<partinfo>BBa_K733008 short </partinfo> | <partinfo>BBa_K733008 short </partinfo> | ||
| − | + | ||
== '''Purpose & Intended Function''' == | == '''Purpose & Intended Function''' == | ||
Our project seeks to design recombinant bacteria that specifically target and suppress the growth of colorectal carcinoma cells in a controllable way. The binding module of our biological system requires expression of a phage display peptide (RPMrel) on the surface of Bacillus subtilis, the organism we have chosen as our carcinoma suppression vector. We chose to use Imperial College London’s 2010 team’s lytC protein cell wall binding domain as an anchor for chassis surface expression of RPMrel. | Our project seeks to design recombinant bacteria that specifically target and suppress the growth of colorectal carcinoma cells in a controllable way. The binding module of our biological system requires expression of a phage display peptide (RPMrel) on the surface of Bacillus subtilis, the organism we have chosen as our carcinoma suppression vector. We chose to use Imperial College London’s 2010 team’s lytC protein cell wall binding domain as an anchor for chassis surface expression of RPMrel. | ||
Revision as of 09:47, 23 September 2012
lytC + linker + FLAG
Purpose & Intended Function
Our project seeks to design recombinant bacteria that specifically target and suppress the growth of colorectal carcinoma cells in a controllable way. The binding module of our biological system requires expression of a phage display peptide (RPMrel) on the surface of Bacillus subtilis, the organism we have chosen as our carcinoma suppression vector. We chose to use Imperial College London’s 2010 team’s lytC protein cell wall binding domain as an anchor for chassis surface expression of RPMrel.
This construct positions the FLAGTM peptide where the RPMrel peptide would otherwise be. Tagging lytC with the versatile FLAGTM peptide provides a range of options for characterizing the expression of lytC. Being able to quantify the number of recombinant cell wall binding domains on the chassis surface would help us provide data linking expression quantity and binding ability. Recombinant B. subtilis transformed for expression of this construct can be tested using immunofluorescence and affinity chromatography to, respectively, localize the protein within the cellular environment and purify the protein for quantification.
Subpart Description
lytC (hydrolase cell wall binding domain) 1-954bp region of the 1491bp coding sequence of the lytC protein. Isolated and submitted as a BioBrick by Imperial College London’s 2010 team (details here).
(EAAAK)n type helical linker Stiff, long helical linker designed to separate fusion proteins with minimal disturbance to the function of both proteins. Features distinct 6 amino acid short linker sequence (SRGSRA) at N-terminal. This sequence was included in construction of the recombinant fusion protein lytC - 3xFLAG by Yamamoto et al (2003) to allow localization of the lytC protein on the cell wall.
FLAGTM peptide 8 amino acid peptide tag used in attachment to the protein-of-interest to facilitate multiple assays. Assays include affinity chromatography (recombinant protein purification), immunofluorescence (protein localization), and protein electrophoresis (protein detection size studies). FLAGTM is a registered trademark of Sigma-Aldrich Corp. Their product website can be accessed here.